IRIS Accounts Production v25.1.3.33 05473049 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh054730492023-08-31054730492024-08-31054730492023-09-012024-08-31054730492022-08-31054730492022-09-012023-08-31054730492023-08-3105473049ns15:EnglandWales2023-09-012024-08-3105473049ns14:PoundSterling2023-09-012024-08-3105473049ns10:Director12023-09-012024-08-3105473049ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3105473049ns10:SmallEntities2023-09-012024-08-3105473049ns10:AuditExemptWithAccountantsReport2023-09-012024-08-3105473049ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3105473049ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3105473049ns10:FullAccounts2023-09-012024-08-310547304912023-09-012024-08-3105473049ns10:OrdinaryShareClass12023-09-012024-08-3105473049ns10:Director22023-09-012024-08-3105473049ns10:CompanySecretary12023-09-012024-08-3105473049ns10:RegisteredOffice2023-09-012024-08-3105473049ns5:CurrentFinancialInstruments2024-08-3105473049ns5:CurrentFinancialInstruments2023-08-3105473049ns5:Non-currentFinancialInstruments2024-08-3105473049ns5:Non-currentFinancialInstruments2023-08-3105473049ns5:ShareCapital2024-08-3105473049ns5:ShareCapital2023-08-3105473049ns5:RetainedEarningsAccumulatedLosses2024-08-3105473049ns5:RetainedEarningsAccumulatedLosses2023-08-3105473049ns5:NetGoodwill2023-09-012024-08-3105473049ns5:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3105473049ns5:FurnitureFittings2023-09-012024-08-3105473049ns5:ComputerEquipment2023-09-012024-08-3105473049ns5:NetGoodwill2023-08-3105473049ns5:NetGoodwill2024-08-3105473049ns5:NetGoodwill2023-08-3105473049ns5:FurnitureFittings2023-08-3105473049ns5:ComputerEquipment2023-08-3105473049ns5:FurnitureFittings2024-08-3105473049ns5:ComputerEquipment2024-08-3105473049ns5:FurnitureFittings2023-08-3105473049ns5:ComputerEquipment2023-08-3105473049ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3105473049ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-3105473049ns10:OrdinaryShareClass12024-08-31054730491ns10:Director12023-08-31054730491ns10:Director12022-08-31054730491ns10:Director12023-09-012024-08-31054730491ns10:Director12022-09-012023-08-31054730491ns10:Director12024-08-31054730491ns10:Director12023-08-31
REGISTERED NUMBER: 05473049 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 August 2024

for

Clinical Cosmetics Limited

Clinical Cosmetics Limited (Registered number: 05473049)






Contents of the Financial Statements
for the Year Ended 31 August 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Certified Accountants' Report 7

Clinical Cosmetics Limited

Company Information
for the Year Ended 31 August 2024







DIRECTORS: Dr IG Anderson
Mrs VL Anderson





SECRETARY: Dr IG Anderson





REGISTERED OFFICE: 7 Swan Street
Seagrave
Loughborough
Leicestershire
LE12 7NL





REGISTERED NUMBER: 05473049 (England and Wales)





ACCOUNTANTS: Charnwood Accountants & Business Advisors LLP
The Point
Granite Way
Mountsorrel
Loughborough
Leicestershire
LE12 7TZ

Clinical Cosmetics Limited (Registered number: 05473049)

Balance Sheet
31 August 2024

31.8.24 31.8.23
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 2,088 1,371
2,088 1,371

CURRENT ASSETS
Debtors 6 2,119 3,812
Cash at bank 1,585 743
3,704 4,555
CREDITORS
Amounts falling due within one year 7 3,128 4,570
NET CURRENT ASSETS/(LIABILITIES) 576 (15 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,664

1,356

CREDITORS
Amounts falling due after more than one year 8 4,736 6,052
NET LIABILITIES (2,072 ) (4,696 )

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings (2,074 ) (4,698 )
SHAREHOLDERS' FUNDS (2,072 ) (4,696 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Clinical Cosmetics Limited (Registered number: 05473049)

Balance Sheet - continued
31 August 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 May 2025 and were signed on its behalf by:





Dr IG Anderson - Director


Clinical Cosmetics Limited (Registered number: 05473049)

Notes to the Financial Statements
for the Year Ended 31 August 2024

1. STATUTORY INFORMATION

Clinical Cosmetics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

These accounts have been prepared on the going concern basis due to the assumption that the company will have the continued support of the directors and creditors going forward.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2000, is being amortised evenly over its estimated useful life of eight years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on cost
Computer equipment - 33% on reducing balance

Going concern
There was a net deficiency of assets of £2,083 at the balance sheet date. The directors have confirmed continued support and consider the company retains sufficient working capital to continue trading for the foreseeable future.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

Clinical Cosmetics Limited (Registered number: 05473049)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 September 2023
and 31 August 2024 60,000
AMORTISATION
At 1 September 2023
and 31 August 2024 60,000
NET BOOK VALUE
At 31 August 2024 -
At 31 August 2023 -

5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 September 2023 3,202 1,849 5,051
Additions 1,020 238 1,258
At 31 August 2024 4,222 2,087 6,309
DEPRECIATION
At 1 September 2023 2,661 1,019 3,680
Charge for year 241 300 541
At 31 August 2024 2,902 1,319 4,221
NET BOOK VALUE
At 31 August 2024 1,320 768 2,088
At 31 August 2023 541 830 1,371

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Other debtors 2,119 3,812

Clinical Cosmetics Limited (Registered number: 05473049)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Bank loans and overdrafts 2,615 2,582
Taxation and social security - 967
Other creditors 513 1,021
3,128 4,570

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.8.24 31.8.23
£    £   
Bank loans 4,736 6,052

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.8.24 31.8.23
value: £    £   
2 Ordinary £1 2 2

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 August 2024 and 31 August 2023:

31.8.24 31.8.23
£    £   
Dr IG Anderson
Balance outstanding at start of year 2,850 -
Amounts advanced - 2,850
Amounts repaid (730 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 2,120 2,850

11. ULTIMATE CONTROLLING PARTY

The controlling party is Dr IG Anderson.

Chartered Certified Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Clinical Cosmetics Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Clinical Cosmetics Limited for the year ended 31 August 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the Board of Directors of Clinical Cosmetics Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Clinical Cosmetics Limited and state those matters that we have agreed to state to the Board of Directors of Clinical Cosmetics Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at
https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Clinical Cosmetics Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Clinical Cosmetics Limited. You consider that Clinical Cosmetics Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Clinical Cosmetics Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Charnwood Accountants & Business Advisors LLP
The Point
Granite Way
Mountsorrel
Loughborough
Leicestershire
LE12 7TZ


27 May 2025